HomeTagsOncolytics Biotech

Oncolytics Biotech

Biotechnology

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

News Desk - May 16, 2024

Oncolytics Biotech® Inc., a leading clinical-stage company specializing in immunotherapy for oncology, announced that it has entered into a preliminary collaboration with the Global...

Biotechnology

Oncolytics Biotech Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer

PR Newswire - December 2, 2022

Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...